Similarly, Transwell assays showed that reduced CIP2A levels diminished the sensitivity of cells to PF treatment (Figure 4G), indicating that PF exerts its anti‐melanoma role in a CIP2A‐dependant manner. Here, CIP2A is linked to melanoma.